Vishnu C. Damalanka

ORCID: 0000-0002-1946-1320

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells”.

A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2108728118

N/A

0DataRank · unranked

120 citations

Vishnu C. Damalanka, Michael A. Tartell, Dong hee Chung, André Luiz Lourenço, Dustin Pwee +18 more

Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer

Cellular and Molecular Life Sciences(2024)10.1007/s00018-023-05071-5

N/A

0DataRank · unranked

15 citations

Ramona Graves‐Deal, Zheng Cao, Galina Bogatcheva, Marisol Ramirez, Sarah Harmych +13 more

Mechanism-Based Macrocyclic Inhibitors of Serine Proteases

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.3c02388

N/A

0DataRank · unranked

6 citations

Victoria Banas, Paolo De Bona, M.M. Kashipathy, K.P. Battaile, Scott Lovell +2 more